This article is more than 5 years old. Information may no longer be current.
NuVasive appoints new executive vice president of international operations
NuVasive Inc. announced Skip Kiil has been appointed as executive vice president, international.
According to a company press release, Kiil will oversee international operations and report to Gregory T. Lucier, the chairman and chief executive officer of the company. Kiil has more than 15 years of experience as a global medical technologies and life sciences business leader. Prior to his position at NuVasive, Kiil served as surgical head, Europe, Middle East, Africa and Russia for Alcon. Prior to Alcon, he worked for the Stryker Corporation for more than 12 years.
“I am excited to welcome Skip as a member of the NuVasive executive leadership team,” Lucier said in the release. “Skip has led complex, global commercial enterprises in Europe, the Middle East, Africa, Japan, Asia Pacific and the United States within the health care and spine technology industries. He brings significant strategic and operational expertise in market entry and development and proficiency in maintaining [profit and loss] P&L responsibility, both of which are key elements as we scale and expand our high-growth international channels. We are pleased to have a global leader of Skip’s caliber join NuVasive’s world-class leadership team at this time as we accelerate past $1 billion in revenue, enhance our international operations and continue to change patients’ lives around the world.”
Reference: